Connect with us

Hi, what are you looking for?

Jewish Business News

Syndicated

BlueTech Research unveils BlueTech 7.0 Intelligence Platform

Platform to provide greater visualization of data and analysis on the water sector with updated tools for improved capability and functionality.

Platform to provide greater visualization of data and analysis on the water sector with updated tools for improved capability and functionality.

Online PR News – 29-September-2014 – BlueTech Research announced the upcoming launch of BlueTech 7.0, the next generation of its interactive Intelligence Platform. BlueTech unveiled changes to its Intelligence Platform that include data visualization and customization tools and enhanced site usability to complement its suite of products and services.

Several new tools available in BlueTech 7.0 increase clarity and insight to allow clients to meet project needs and overall organizational objectives. The BlueTech Informatics tool enables clients to access a library of BlueTech data models and charts that can then be customized based on a clients project. The BlueTech Innovation Impact Analysis tool assesses the effect of disruptive technologies on existing markets and the timeline for market impact.

Using BlueTech 7.0, our BlueTech research analysts customize data to provide tailored client engagement, said Jeff Guild, Vice President, Business Development and Professional Services. These new BlueTech 7.0 tools were specifically developed to support our clients, integrating into the daily work flow of a CTO, R&D manager, knowledge management and new business development positions. Each can access and utilize different tools and products to support day-to-day operations.

Clients will also benefit from updates to the Innovation Tracker, with streaming updates in the newsfeed on Innovation Tracker companies clients have marked as favorite. Clients can also track the progression of these companies through the commercialization process. Enhanced site speed and search features allow users to more easily explore the library of BlueTech data, including market insight reports, company profiles, and the Innovation, Patent and Licensing Trackers.

We want to make our clients jobs easier, especially as it relates to making sound business decisions. The Intelligence Platform allows users to more easily access and analyze data through our improved tools and better grasp the changing water landscape. Where is technology innovating? What emerging technologies are disrupting existing markets? Where is there potential for growth and development? BlueTech 7.0 offers market intelligence to successfully identify key opportunities and emerging trends in the global water industry, said Tyler Algeo, BlueTech Research.

BlueTech 7.0 will officially launch at WEFTEC 2014 in New Orleans, LA, September 27-October 1. Previews of the BlueTech 7.0 Intelligence Platform are available through bluetechresearch.com, with complete access available to members of the BlueTech Research Advisory Service.

About BlueTech Research
BlueTech Research, an O2 Environmental company, is an independent water technology market intelligence firm. We provide actionable insights to a global client base on innovative and disruptive technologies, market direction, market opportunities, and access to intelligence on the companies innovating in the water space.

Company Contact Information
Joan Steiger
bluetechresearch.com
4072676839
 
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış cialis